Ataxia Telangiectasia Mutated ProteinsCell ProliferationClonal Hematopoiesis
Dr. Christopher Reid Reilly, MD
NPI1598185050PAC ID4880992866
- Medicare services, 2024
- 53
- Medicare patients, 2024
- 40
- Part D claims, 2024
- 141
- Publications
- 14
- MIPS score, 2024
- 84
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Reilly's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Christopher Reid Reilly is a medical oncologist in Boston, Massachusetts
Dr. Reilly practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Dr. Reilly's NPI, 1598185050, was assigned on April 23, 2014. Dr. Reilly graduated from Univ of Central Florida, College of Medicine in 2014. Dr. Reilly holds Massachusetts license 274014.
NPI and contact details
- NPI
- 1598185050NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4880992866
- NPI enumeration date
- April 23, 2014
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 38
- Medical school graduation
- 2014
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Christopher Reid Reilly practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Dr. Reilly's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Dr. Christopher Reid Reilly is affiliated with 3 sites of care and 1 medical group
Dr. Reilly's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Reilly is also affiliated with Massachusetts General Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Reilly to 1 more hospital, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Christopher Reid Reilly's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reilly practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Reilly practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Christopher Reid Reilly is one of 290 medical oncologists in Massachusetts
Medical oncology is Dr. Reilly's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Reilly is licensed in Massachusetts.
Specialties and state licenses
- Medical oncology, MassachusettsPrimary
Medical oncologists near Dr. Reilly
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
290medical oncologists in Massachusetts228medical oncologists in Boston96medical oncologists at Dana-Farber Cancer Institute
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Christopher Reid Reilly billed Medicare for 53 services in 2024
CMS data shows 53 Medicare services from Dr. Reilly across 2 procedure codes in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $5,064 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 202453
Medicare patients40
Paid by Medicare$5,064
Procedure codes2
Dr. Reilly's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1762024: 5370%
Dr. Reilly compared with the Massachusetts median for medical oncologists, 2024
- Dr. Reilly
- Massachusetts median
- Medicare services
- 53vs 26080% below
- Medicare patients
- 40vs 10963% below
- Part D claims
- 46vs 6327% below
Medians across 259 medical oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Reilly's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Reilly?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Reilly and other medical oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Christopher Reid Reilly treated 40 Medicare patients in 2024, average age 71
CMS counts 40 Medicare patients who saw Dr. Reilly in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Reilly's median patient age at 47, with 47% women.
Medicare patients, 202440
Average age71
Average risk score2.56
Dr. Reilly's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Reilly's Medicare patients by sex, 2024
- Women2563%
- Men1538%
Chronic conditions among Dr. Reilly's Medicare patients, 2024
- High blood pressure75%
- High cholesterol73%
- Anxiety40%
- Arthritis40%
- Chronic kidney disease35%
- Ischemic heart disease35%
- Osteoporosis33%
- Cancer28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Reilly's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 47
Patient panel by sex, all payers
- Women47%
- Men52%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Christopher Reid Reilly wrote 141 Medicare Part D claims in 2024
In 2024, Dr. Reilly wrote 141 Medicare Part D claims for 12 patients. 96% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $840 in total drug cost. In 2022, CMS named 13 claims across 1 drug.
Part D claims, 2024141
Drugs named by CMS3
Total drug cost$840
Part D patients12
Dr. Reilly's Part D claims by kind of drug, 2024
- Generic136 claims96%
- Brand-name and other5 claims4%
Dr. Reilly's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2024
- 2022
- 2024
- Claims for drugs CMS names
- 2022: 132024: 46254%
Drugs named by CMS: 3 in 2024, 1 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Christopher Reid Reilly scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Reilly for performance year 2024, reported as part of a group. Dr. Reilly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reilly as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Reilly's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Reilly by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Christopher Reid Reilly has 14 publications on record
Dmand AI links 14 papers to Dr. Reilly, published from 2017 to 2025. 2021 was the busiest year, with 2. The most frequent topics are Myeloproliferative Disorders, Bone Marrow Diseases and Exocrine Pancreatic Insufficiency. Dr. Reilly has published most often in Blood. Dr. Reilly's most frequent co-authors are Akiko Shimamura, MD, PhD, Suneet Agarwal, MD and Ilene Ann Galinsky, ADT, NURSE, Practioner.
Papers14
Years published2017 to 2025
Dr. Reilly's papers by year, 2017 to 2025
Topics Dr. Reilly writes about most
- Myeloproliferative Disorders
- Bone Marrow Diseases
- Exocrine Pancreatic Insufficiency
- Lipomatosis
- Myelodysplastic Syndromes
- Shwachman-Diamond Syndrome
- Telomere
Dr. Reilly's most frequent co-authors
- Akiko Shimamura, MD, PhD4 shared papers
- Suneet Agarwal, MD3 shared papers
- Ilene Ann Galinsky, ADT, NURSE, Practioner3 shared papers
Recent publications by Dr. Reilly
Bone Marrow CellsJanus Kinase 2Myeloproliferative Disorders
See who Dr. Reilly researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Reilly works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Christopher Reid Reilly received $57 in industry payments in 2022
CMS Open Payments shows 2 general payments to Dr. Reilly from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. BeiGene, Ltd. paid the most, $57.
Companies that paid Dr. Reilly the most, 2022 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Christopher Reid Reilly graduated from Univ of Central Florida, College of Medicine
Dr. Reilly graduated from Univ of Central Florida, College of Medicine in 2014.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Christopher Reid Reilly's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Christopher Reid Reilly
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Christopher Reid Reilly's NPI number?
Dr. Christopher Reid Reilly's NPI number is 1598185050. It was assigned on April 23, 2014, and it is active in the NPI Registry.
What kind of doctor is Dr. Christopher Reid Reilly?
Dr. Christopher Reid Reilly is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Christopher Reid Reilly practice?
Dr. Reilly practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Reilly's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Reilly to 1 hospital.
What is Dr. Christopher Reid Reilly's medical license number?
Dr. Reilly holds Massachusetts license 274014.
Which hospitals is Dr. Christopher Reid Reilly affiliated with?
Dr. Reilly practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Reilly is also affiliated with Massachusetts General Hospital. Dmand AI links Dr. Reilly to 1 more hospital.
What medical group is Dr. Christopher Reid Reilly part of?
Dr. Reilly is linked to Binney Medical Group.
Does Dr. Christopher Reid Reilly accept Medicare?
Yes. CMS data shows Dr. Reilly billed Medicare for 53 services in 2024, and Dr. Reilly accepts Medicare assignment.
Does Dr. Christopher Reid Reilly offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Reilly as offering telehealth services.
What is Dr. Christopher Reid Reilly's MIPS score?
Dr. Reilly's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Christopher Reid Reilly see?
CMS counts 40 Medicare patients who saw Dr. Reilly in 2024, with an average age of 71.
Show 7 more questionsShow fewer questions
What services does Dr. Christopher Reid Reilly bill to Medicare?
In 2024, Dr. Reilly's most billed Medicare services were office visit, established patient (99214) and office visit, new patient (99205).
Where did Dr. Christopher Reid Reilly go to medical school?
Dr. Reilly graduated from Univ of Central Florida, College of Medicine in 2014.
What drugs does Dr. Christopher Reid Reilly prescribe most?
In 2024 Medicare Part D data, Dr. Reilly's most prescribed drugs by claims were Prednisone, Acyclovir and Mycophenolate Mofetil.
Has Dr. Christopher Reid Reilly received payments from drug or device companies?
CMS Open Payments shows $57 in general payments to Dr. Reilly from 1 company from 2022 to 2022. The largest total came from BeiGene, Ltd.
How long has Dr. Christopher Reid Reilly been practicing?
Dr. Reilly graduated from medical school in 2014, 12 years ago.
Does Dr. Christopher Reid Reilly do research?
Dmand AI links 14 publications to Dr. Reilly, published from 2017 to 2025.
Who does Dr. Christopher Reid Reilly publish with?
Dr. Reilly's most frequent co-authors are Akiko Shimamura, MD, PhD (4 shared papers), Suneet Agarwal, MD (3 shared papers) and Ilene Ann Galinsky, ADT, NURSE, Practioner (3 shared papers).
Selling to medical oncology practices?
See medical oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card